In this paper I want to consider what, if anything, cell hybridization has contributed to our knowledge of malignant disease in animals, and whether it is possible that the technique would be useful in studies on human tumour cells. I shall deal almost exclusively with cell fusion produced by Sendai virus inactivated by ultraviolet light (Watkins, 1971 (Watkins, 1970 virus, but the proportion could not be increased by treatment with iododeoxyuridine. In addition, hybridization in situ with heavily labelled RNA complementary to SV40 DNA showed that 2-3 % of the cells were synthesizing viral DNA. The picture which begins to emerge from these and other studies suggests that SV40 virus may exist in a tumour cell line in one of two forms, possibly integrated and non-integrated. If the cell is capable of replicating the viral DNA it will do so when the virus is in the non-integrated form, but it will not go on to synthesize viral capsid protein until other conditions of an unknown kind are satisfied. Non-permissiveness may therefore be due to two blocks, in viral DNA synthesis and in viral protein synthesis. This model may be relevant to a consideration of the natural history of EB virus of Burkitt's lymphoma.
In contrast to SV40 virus, the related polyoma virus has not been recovered from transformed cells by fusion with permissive cells. Cell fusion is relevant to studies on C-type RNA viruses mainly in situations where the virus has transformed cells of a species other than its natural host. Svoboda and 16 Dourmashkin (1969) , for example, have recovered Rous sarcoma virus from transformed hamster cells by fusing them with chicken fibroblasts.
It will be obvious that the application of cell fusion to the search for a human tumour virus is not straightforward. First a cell line permissive for the putative virus must be found; this means that any human tumour must be screened against a wide range of cell types. Secondly, even if a permissive cell line could be found, the virus might behave like polyoma rather than SV40. If one speculated that a human tumour were caused by a C-type RNA virus from another species, for example, domestic cats or dogs, then, by analogy with Svoboda's studies on Rous virus, it might be worth using cells of the species in question in fusion studies.
Genetic Analysis of Malignancy
In the early 1960s Barski and Cornefert (1962) carried out some experiments to determine whether a hybrid line between a malignant cell and a nonmalignant cell would be malignant or nonmalignant. They concluded that the hybrid was malignant. Recently Klein and Harris (see Harris, 1971 ) and their colleagues re-investigated the question, using several different tumours of inbred mice crossed with a line of cells derived from C3H mouse fibroblasts, and concluded that the hybrid was not malignant. They found, however, that the hybrid would revert to malignancy, and that the reversion was accompanied by a reduction in the number of chromosomes which had arisen from the normal parent. Two interpretations are possible. One is that reversion to malignancy occurred first, by some unknown genetic change, and the consequent rapid growth led to chromosome reduction; the other is that one or more chromosomes of the normal parent carry genes capable of suppressing malignancy, and reversion occurs because of random loss of certain chromosomes, among which may be chromosomes carrying suppressor genes. The second interpretation is supported by their finding that a hybrid formed between tumour cells and a malignant subclone of the original normal parent gave rise to a tumour in which there was little or no reduction in chromosome number in comparison with the population injected; that is, rapid growth, per se, of a hybrid tumour did not lead to gross chromosome loss. Future work with this system requires the demonstration that suppression of malignancy is associated with a particular chromosome or chromosomes but this is impossible in the absence of a method for selecting, in vivo, nonmalignant cells from malignant cells. There are no signs yet of such a method, which would, in itself, contribute greatly to the solution of the cancer problem.
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